EP3329924
DSRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.3.2011EP published:
5.5.2021EP application number:
17187246.8
EPO information:
European Patent Register
Max expiry date:
28.3.2031
Title:
DSRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS
Timeline
Today
29.3.2011EP application
5.5.2021EP Publication
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
300 Third Street, 3rd Floor, Cambridge, MA 02142, US
Name:
Kumamoto UniversityAddress:
39-1 Kurokami 2-chome, Kumamoto-shi Kumamoto 860-8555, JP
Inventor
Name:
ALVAREZ, ReneAddress:
Cambridge, MA 02142, US
Name:
SAH, Dinah Wen-YeeAddress:
Cambridge, MA 02142, US
Name:
ANDO, YukioAddress:
Kumamoto 860-8555, JP
Name:
JONO, HirofumiAddress:
Kumamoto 860-8555, JP
Priority
Number:
318702 PDate:
29.3.2010Country:
US
Number:
318704 PDate:
29.3.2010Country:
US
Classification
Categories:
A61K 31/7088, C07H 21/02, A61K 48/00, A61K 31/7115, A61K 31/713, C12N 15/113, A61P 27/02